M&A Deal Summary

Accelmed Acquires Bioventus - Advanced Rehabilitation Business

On October 1, 2024, private equity firm Accelmed acquired medical products company Bioventus - Advanced Rehabilitation Business from Bioventus for 45M USD

Acquisition Highlights
  • This is Accelmed’s 12th transaction in the Medical Products sector.
  • This is Accelmed’s largest (disclosed) transaction.
  • This is Accelmed’s 14th transaction in the United States.

M&A Deal Summary

Date 2024-10-01
Target Bioventus - Advanced Rehabilitation Business
Sector Medical Products
Buyer(s) Accelmed
Sellers(s) Bioventus
Deal Type Divestiture
Deal Value 45M USD

Target

Bioventus - Advanced Rehabilitation Business

United States
Bioventus' Advanced Rehabilitation Business is a provider of medical products critical for helping patients with stroke and other neuromuscular conditions in their rehabilitation journey.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

DESCRIPTION

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.


DEAL STATS #
Overall 18 of 18
Sector (Medical Products) 12 of 12
Type (Divestiture) 1 of 1
Country (United States) 14 of 14
Year (2024) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-23 Trukera Medical

Southlake, Texas, United States

Trukera Medical develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve the standard of care by objectively testing for disease biomarkers in tears at the point-of-care. Trukera Medical is based in Southlake, Texas.

Sell -

Seller(S) 1

SELLER

Bioventus

Durham, North Carolina, United States

Category Company
Founded 2011
Sector Medical Products
Employees995
Revenue 512M USD (2023)
DESCRIPTION

Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.


DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Divestiture) 2 of 2
Country (United States) 1 of 1
Year (2024) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-24 CartiHeal

Kfar-Saba, Israel

CartiHeal is a privately-held medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal founded in 2009 and is based in Kfar-Saba, Israel.

Sell $330M